Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
BMC Microbiol ; 16(1): 158, 2016 07 20.
Artículo en Inglés | MEDLINE | ID: mdl-27439312

RESUMEN

BACKGROUND: Pet is a toxin from the family of Serine Protease Autotransporters of Enterobacteriaceae which was initially identified in Enteroaggregative Escherichia coli strains. This protease exhibits enterotoxin properties, damages the cell cytoskeleton and induces intestinal epithelium alterations, which are associated with a severe inflammatory process. An in-vitro study was conducted to evaluate the effect of Pet on the migration of human peripheral blood monocytes-derived macrophages and its participation in the activation of the early inflammatory response and cytokine expression. RESULTS: In the macrophage migration activation assay, Pet produced a similar effect to that induced by opsonized zymosan (ZAS). Regarding the cytokine expression, an increase of IL-8, TNF-α (pro-inflammatory) and IL-10 (anti-inflammatory) was identified. In addition to the above results, the nuclear translocation of NF-kB pp65 was also identified. These events are probably related to the inflammatory response identified in the histological examination of intestine rat samples inoculated with Pet during a ligated loop assay. CONCLUSION: The results showed that Pet participates as an immunostimulant molecule for macrophages, which activates both their mobility and cytokine expression. These observations suggest that the toxin participates in the inflammatory process that is observed during the host infection by EAEC Pet producing.


Asunto(s)
Toxinas Bacterianas/química , Toxinas Bacterianas/toxicidad , Enterotoxinas/química , Enterotoxinas/toxicidad , Proteínas de Escherichia coli/química , Proteínas de Escherichia coli/toxicidad , Escherichia coli/enzimología , Activación de Macrófagos/efectos de los fármacos , Serina Endopeptidasas/química , Serina Endopeptidasas/toxicidad , Animales , Toxinas Bacterianas/metabolismo , Línea Celular , Quimiotaxis/efectos de los fármacos , Citocinas/biosíntesis , Citocinas/inmunología , Citoesqueleto/metabolismo , Enterotoxinas/metabolismo , Proteínas de Escherichia coli/metabolismo , Humanos , Inmunidad Innata , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/patología , Macrófagos/efectos de los fármacos , Macrófagos/inmunología , Macrófagos/metabolismo , Fagocitosis , Ratas , Ratas Sprague-Dawley , Serina Endopeptidasas/metabolismo , Zimosan
2.
Biol Trace Elem Res ; 120(1-3): 133-40, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17916965

RESUMEN

Most zinc studies show its benefits or changes that coincide with its deficiency, but some have reported damages by supplements. In this work, the effects of zinc in different cell lines (U-937, human monocytes, and murine bone marrow cells) were analyzed. The cells were put in their specific culture medium either alone or with a stimulant [1-phorbol 12-myristate 13-acetate (PMA) for U-937 and monocytes, granulocyte macrophage colony stimulating factor (GM-CSF) for bone marrow cells]. These preparations, with or without zinc (0.05 to 1.0 mM), were incubated and microscopically analyzed on days 3, 9, and 11. The viability of all cells cultivated with 0.05 and 0.1 mM of zinc was similar to that of the controls without zinc (90%). With 1.0 mM of zinc, the viability diminished (p < 0.005) to 80% in U-937 and to 50% in monocytes and bone marrow cells; the number of cells increased in the three lines, but there was no differentiation. We conclude that the effects observed with different doses of zinc vary not only among the different species but also according to the time the cells were exposed to the metal. The same doses of zinc can have either a stimulatory or an inhibitory effect.


Asunto(s)
Diferenciación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Zinc/farmacología , Animales , Células de la Médula Ósea/efectos de los fármacos , Humanos , Ratones , Monocitos/efectos de los fármacos , Células U937
3.
Arch Invest Med (Mex) ; 21 Suppl 1: 245-7, 1990.
Artículo en Español | MEDLINE | ID: mdl-1967028

RESUMEN

The supernatant fluid of axenically grown E. histolytica contains a factor (MLIF) which inhibits the locomotion of human monocytes (including chemotaxis) without affecting that of human polymorphonuclear leucocytes. Locomotion, like other cellular functions, is modulated by changes in intracellular cAMP and cGMP. The consensus--with some exceptions--is that while rises in cGMP accompany locomotion, an increase in cAMP (without a concomitant fall in -cGMP) occurs with inhibition of cellular movement. We measured by radioimmunoassay the cAMP concentration of human monocytes exposed to inhibitory concentrations of MLIF. A significant (p less than 0.005) rise in monocyte cAMP was found, comparable to that observed with the use of forskolin, a well known cAMP stimulator. The control studies using plain axenic medium, not only failed to reveal any rise in cAMP but disclosed a small, yet not significant drop in intracellular cAMP. These results suggest that MLIF (like other locomotion inhibitors, i.e. prostaglandins E1, A1 and isoproterenol) produces a significant increase in intracellular monocyte cAMP. This modification in intracellular signals may contribute to the inhibition in monocyte locomotion, an event during which an increase in pericentriolar microtubules has also been observed.


Asunto(s)
AMP Cíclico/biosíntesis , Entamoeba histolytica/química , Factores Inhibidores de la Migración de Leucocitos/aislamiento & purificación , Leucocitos Mononucleares/fisiología , Animales , Movimiento Celular/fisiología , Humanos , Factores Inhibidores de la Migración de Leucocitos/fisiología , Leucocitos Mononucleares/metabolismo , Leucocitos Mononucleares/ultraestructura , Microtúbulos/ultraestructura , Neutrófilos/fisiología , Sistemas de Mensajero Secundario
4.
Arch Invest Med (Mex) ; 20(1): 79-86, 1989.
Artículo en Español | MEDLINE | ID: mdl-2764671

RESUMEN

Levels of complement fractions of 12 patients with sporadic ankylosing Spondylitis and 6 patients with familial Ankylosing Spondylitis (N. Y. Criteria) were studied by an hemolytic and functional method (microhemolysis in plate. Cordis Lab. Miami, Fla. USA). Abnormal levels were found in 94% of them high levels of C1 and C2 (p 0.002), and C3 (p 0.05) C8 and C9 (p 0.001) deficiencies, mixed or isolated, correlated with the severity of the diseases. C9 deficiency belongs to familial Ankylosing Spondylitis. These functional deficiencies of serum complement can favor the colonization and persistence of germs, which could mediate in the genesis of Ankylosing Spondylitis.


Asunto(s)
Proteínas del Sistema Complemento/análisis , Espondilitis Anquilosante/sangre , Espondilitis Anquilosante/inmunología , Adolescente , Adulto , Niño , Proteínas del Sistema Complemento/genética , Proteínas del Sistema Complemento/inmunología , Femenino , Humanos , Masculino , Linaje , Espondilitis Anquilosante/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA